UCSF Neurological Surgery faculty since 2003
 
Read about Dr. Hodgson's current research
 
Dr. Hodgson's research program focuses on the discovery and characterization of genes important in brain tumor formation, and assessment of their clinical potential as biomarkers and therapeutic targets. His lab interacts closely with neurosurgeons, neuro-oncologists, pathologists, and basic researchers in the Department to facilitate the translation of genome-based molecular discoveries to clinical practice.
 
Education, Training, and Previous Positions
 
1994: BSc, University of Guelph, Ontario, Canada
1999: PhD, University of British Columbia
1999-2002: Postdoctoral Fellow, University of California, San Francisco
2002-2003: Assistant Research Biochemist, Department of Laboratory Medicine, UCSF
 
Selected Professional Memberships and Appointments
 
American Association for Cancer Research
Society of Neuro-Oncology
 
Selected Honors and Awards
 
1993: Undergraduate Studentship, National Sciences and Engineering Research Council
1993: College Roll of Distinction, University of Guelph
1994-1996: PGS-A Post Graduate Scholarship, National Sciences and Engineering Research Council
1996-1998: PGS-B Post Graduate Scholarship, National Sciences and Engineering Research Council
2000: President's Award of Excellence, International Society of Analytical Cytology
2001-2004: Postdoctoral Fellowship, U.S. Department of Defense Breast Cancer Research Program
2004-present: Howard Temin Award, National Cancer Institute
 
Contact
 
Graeme Hodgson PhD
University of California, San Francisco
Department of Neurological Surgery, N-171, Box 0808
San Francisco, CA. 94143-0808
Phone: (415) 476-3630
 
Selected Recent Publications
 
Hodgson JG, Malek T, Bornstein S, Hariono S, Ginzinger DG, Muller WJ, Gray JW. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 2005;65(21):9695-704.
 
Hong C, Maunakea A, Jun P, Bollen AW, Hodgson JG, Goldenberg DD, Weiss WA, Costello JF. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8. Cancer Res 2005;65(9):3617-23.
 
Hager JH, Hodgson JG, Fridlyand J, Hariono S, Gray JW, Hanahan D. Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas. Cancer Res 2004;64(7):2406-10.
 
Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003;300(5618):489-92.
 
Hackett CS, Hodgson JG, Law ME, Fridlyand J, Osoegawa K, de Jong PJ, Nowak NJ, Pinkel D, Albertson DG, Jain A, Jenkins R, Gray JW, Weiss WA. Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. Cancer Res 2003;63(17):5266-73.
 
Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, Moore D, Nowak N, Albertson DG, Pinkel D, Collins C, Hanahan D, Gray JW. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001;29(4):459-64.